WINNIPEG, MB / TheNewswire / April 2, 2019 – DELTA 9 CANNABIS INC. (TSXV: NINE) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce the grand opening of its Delta 9 Cannabis Superstore in the Brandon Shoppers Mall in the City of Brandon, Manitoba. The Company is also reporting it has now surpassed 100,000 retail cannabis transactions since legalization of recreational-use cannabis last fall.
“With this newest store opening we’re extremely excited to be able to offer the citizens of Brandon a truly unique retail cannabis shopping experience” said John Arbuthnot, CEO. “Delta 9’s Cannabis Superstore concept combined with our focus on convenient and high traffic shopping destinations have been very successful as a part of our company’s overall vertical integration strategy.”
At approximately 4,500 square feet the newest Delta 9 Cannabis Superstore is one of the largest cannabis retail stores in the country, offering customers an open and modern shopping decor, highly trained staff and a wide range of product SKU’s including dried cannabis flower, cannabis oil, a full assortment of cannabis accessories, and a large customer education center providing customers with education programing for the adult recreational market.
The store is conveniently located in the Brandon Shoppers Mall at 1570-18th Street in Brandon. The Mall is a 367,000-square-foot enclosed regional shopping center located in Brandon, Manitoba. The mall features more than 90 retailers including Shoppers Drug Mart, Sobeys, Dollarama, Sport Chek, and Landmark Cinemas, offering a merchandise mix of retail, services, entertainment and restaurants.
Delta 9, through its partially-owned subsidiary, Delta 9 Lifestyle Cannabis Clinic Inc., successfully launched its first retail cannabis store in Winnipeg, Manitoba on October 17, 2018. The Company plans to open an additional retail outlet in Thompson, Manitoba in the near future, and has partnered with a Manitoba First Nation to open a fifth store. Additionally, the Company has prequalified for the Manitoba government’s request for proposals to open additional stores in smaller, rural communities. The Company plans to pursue additional expansion opportunities in cannabis retail across Canada over the course of the year.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the Cannabis Regulations (CR) and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE” and on the OTC under the symbol VRNDF. For more information, please visit delta9.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) Delta 9’s expansion plans for its Winnipeg production facilities and for its network of retail stores; (ii) Delta 9’s capital raising plans; (iii) Delta 9’s production of cannabis; and (iv) costs for Delta 9’s expansion plans. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including: (i) Delta 9’s ability to raise sufficient capital for its expansion plans; and (ii) Delta 9 obtaining all regulatory approvals, as well as all risk factors set forth in the annual information form of Delta 9 dated May 31, 2018 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.